Background
Nine secretory proprotein convertases (PCs) of the subtilisin/kexin type (genes
PCSK1 to
PCSK9) were identified in mammals and are known as: PC1/3, PC2, furin, PC4, PC5/6, PACE4, PC7, SKI-1/S1P and PCSK9 [
1,
2]. The first 7 convertases cleave secretory precursor proteins at single or paired basic residues [
2], whereas SKI-1/S1P [
3] and PCSK9 [
4] do not require a basic residue at the cleavage site. The basic amino acid (aa)-specific convertases process precursors of growth factors, receptors, polypeptide hormones, adhesion molecules, proteases, as well as cell surface proteins of infectious viruses and bacteria [
2]. In some cases, furin and/or PC5/6 inactivate proteins such as endothelial and lipoprotein lipases [
5], PCSK9 [
6] and N-cadherin (Maret D.
et al.,
submitted).
Overexpression of PC5/6, PACE4 and furin revealed that these proteinases can often cleave the same precursors, indicating a functional redundancy [
6‐
12]. Evidence for
in vivo redundancy was provided by furin inactivation in the liver, which revealed that most of the precursors analyzed were still processed, although to a lesser extent, in the absence of this ubiquitous convertase [
13]. In contrast,
in vivo studies demonstrated that in a spatio-temporal manner furin can uniquely process the Ac45 subunit of the vacuolar type H
+-ATPase in pancreatic β-cells [
14] and PC5/6 the TGFβ-like growth and differentiation factor Gdf11 in the developing embryo [
15,
16].
Various precursors cleaved by overexpressed furin, PC5/6, PACE4 and PC7 have been previously implicated in cancer and associated metastatic processes [
17‐
19]. A correlation between the mRNA levels of some of these PCs and the degree of tumorigenicity has been reported [
9,
18‐
27]. Furthermore, injection/implantation of various cell lines expressing PC inhibitors, such as the antitrypsin derivative α1-PDX [
9,
12,
20,
24,
27,
28] or the inhibitory prodomain of PCs [
26] suggested a critical role of the PCs in tumor growth and/or metastasis.
The convertase PC5/6 (previously known as PC5 or PC6) was characterized in 1993 and shown to be composed of two differentially spliced isoforms, a short 915 aa soluble PC5/6A [
29], and a long membrane-bound 1877 aa PC5/6B [
30]. In adult rodents, PC5/6 exhibits a wide tissue distribution [
29], which in mice when analyzed by quantitative PCR (QPCR) revealed that the adrenal cortex and small intestine are the richest sources of PC5/6A and PC5/6B, respectively [
31]. However, the function of PC5/6 in these tissues has not been addressed. PC5/6 can bind cell surface heparan sulfate proteoglycans and tissue inhibitors of metalloproteases
via its C-terminal Cys-rich domain [
32]. It also seems to differ from the other convertases in that it can get activated at the cell surface [
1,
33]. Knockout of the PC5/6 gene (
Pcsk5) revealed that
Pcsk5-/- animals die at birth due to multiple malformations, including defects in antero-posterior patterning and heart formation [
15,
16]. Defective specification of segment identity, which leads to an increased number of thoracic and lumbar vertebrae and lack of tail, is likely due to the absence of processing of Gdf11 [
15,
16,
34]. No obvious malformations were seen in the small intestine of
Pcsk5-/- embryos [
15].
The specific role of PC5/6 in tumorigenesis/metastasis has not yet been investigated. PC5/6 expression was not detected in human breast, and generally not induced in breast cancer since it was present in only 2/30 tumors [
35]. In contrast, its mRNA levels seem to correlate with tumor aggressiveness of head and neck- and lung tumor-derived cell lines [
18], suggesting that PC5/6 may play a different role in metastasis compared to tumor growth. Whether this is related to its ability to process adhesion molecules [
36], including the α-chain of various integrins [
7,
37] and N-cadherin (Maret D.
et al.,
submitted) is not yet clear.
Colorectal cancer is the third most common form of cancer in the Western world. As a mouse model for this pathology, we used the
ApcMin/+strain that harbors a heterozygote
Min (
multiple intestinal neoplasia) mutation in the
Apc (adenomatous polyposis coli) gene. These mice spontaneously develop polyps all along the small intestine [
38,
39]. In order to assess the role of PC5/6 in intestinal tumorigenesis, we generated PC5/6 intestine-specific knockout mice (iKO) and crossed them with
ApcMin/+mice. Our data show that mice carrying the
Min mutation but lacking PC5/6 tend to exhibit a higher tumor number than
ApcMin/+mice, especially in duodenum, and die significantly earlier.
Discussion
The use of general PC-inhibitors such as α1-PDX or pro-furin revealed that PC-inhibition decrease tumorigenesis and metastasis in nude mice [
9,
12,
20,
26], but enhance metastasis in immunosuppressed newborn rats [
43]. This is probably due to the ability of overexpressed PC-inhibitors to block the activity of more than one convertase [
44], which may exert opposite regulating effects and modulate multiple processes. Thus, mice lacking a specific convertase should represent a more powerful tool to assess the specific function of a single convertase. Of all the PC knockout mice, those lacking furin [
45] and PC5/6 [
15,
16] exhibit a fully penetrant embryonic lethal phenotype, precluding their use in adult mouse studies. Tissue-specific knockouts thus provide a potential approach to test their effect in cancer/metastasis. So far, the
in vivo role of a specific PC in tumorigenesis was only investigated in mice lacking furin in salivary glands among other tissues [
46]. In these mice, the simultaneous inactivation of furin and overexpression of the
PLAG1 transcription factor, which induced the formation of adenomas in salivary glands, showed that the absence of furin delayed tumorigenesis [
46], suggesting a pro-tumorigenic effect of furin.
The present study is the first attempt to assess the role of PC5/6 in cancer development using knockout mice. The impact of PC5/6 has been analyzed here exclusively
in vivo, using the
ApcMin/+intestinal tumorigenesis model. We first evaluated PC5/6 mRNA levels in intestinal tumors
versus normal tissue obtained from colon cancer patients (Figure
1A) or
ApcMin/+mice (Figure
1B and
1C), and showed that PC5/6 is systematically down-regulated in intestinal tumors. To probe the role of PC5/6 in tumorigenesis, we compared the number and size of intestinal tumors in
ApcMin/+mice lacking or not PC5/6 (Figure
4). The data showed a trend for an enhanced tumorigenesis in PC5/6-deficient mice, reaching significance only in the duodenum (Figure
4B) where PC5/6 is primarily expressed (Figure
2A), suggesting that it may exert specific functions therein. This result was unexpected in view of the reported reduced tumorigenesis by general PC-inhibitors [
18,
20‐
22].
Could PC5/6 specifically process a tumor-suppressor or inactivate a tumorigenic factor, and hence act in an opposite fashion to other basic aa-specific PCs? Opposing functions can occur by cleavage of the same substrate at different sites, as illustrated by the ability of furin to activate the cell adhesion molecule N-cadherin and PC5/6 to inactivate it (Maret D.
et al.,
submitted). In the duodenum, PC5/6 was only 1.7-fold less abundant than furin, while its ratio to furin was 3- to 10-fold lower in other segments of the intestine [see Additional file
44: figure S4]. Thus, tumorigenesis in the duodenum may depend on the balance between activation and/or inactivation of proteins by resident furin and PC5/6, respectively. In tumors of the duodenum, PC5/6 mRNA levels are ~ 7-fold lower than those of furin (Figure
1C). Thus, the pro-tumorigenic properties of furin [
46] may in some cases overshadow the protective effect of PC5/6. We surmise that within the duodenum, furin may activate precursors implicated in epithelial to mesenchymal transition, involved in early tumorigenesis and invasion/metastasis [
47], such as E-cadherin [
48] and TGF-β [
49], while PC5/6 may inhibit tumorigenesis, e.g.,
via inactivation of adhesion proteins such as N-cadherin (Maret D.
et al.,
submitted), resulting in a lower number of tumors.
Conclusion
Future studies aimed to identify the implicated substrates will require an extensive comparative analysis of
ApcMin/+-induced tumors isolated from mice lacking PC5/6, furin or both in enterocytes. Whether the mechanism behind the shortened survival of
ApcMin/+mice lacking PC5/6 (Figure
5) is due to more severe hemorrhages resulting from a greater vessel fragility induced by the loss of PC5/6 [
15] would require a more detailed examination. Furthermore, the importance of specific PCs in the invasion/metastasis process, which is heavily regulated by adhesion molecules processed by PCs [
17,
27] is yet to be fully investigated in an appropriate
in vivo model. Finally, this is the first report that emphasizes the opposite roles of furin and PC5/6 in tumorigenesis. Thus, recently proposed treatments aimed to reduce furin activity [
9,
18‐
27] should include careful monitoring of their effects on PC5/6 levels and/or activity.
Competing interests
This work was supported by Canadian Institutes of Health Research grant # 44363, a Canada Chair # 201652, and a Strauss foundation grant. The authors declare that they have no competing interests.
Authors' contributions
All authors read and approved the final manuscript.
XS carried out all the mouse analyses, tumor measurements and other experiments as well as the genotyping. RE generated the PC5/6 conditional knockout mice and helped in the analyses of their phenotypes, NGS participated in the design of the experiments, analysis of the data and writing of the manuscript, and AP was the major driver of the project implicated in all aspects of the research.